P3 Health Partners Inc. Common Stock (PIII) Stock Price

PIIIStock

$4.14−53.06%52W

Market Cap$843.68M

P/E—

PEG Ratio—

Div yield—

Beta1.86

PIII Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)61.88%

Price vs S&P 500 (4W)-44.20%

VGM Score58.27

Book Value / Share (Quarterly)$18.46

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)11.61%

Cash Flow / Share (Quarterly)$-33.41

Price vs S&P 500 (YTD)6.70%

Gross Margin (TTM)4.70%

Net Profit Margin (TTM)-6.55%

EPS (TTM)$-30.32

10-Day Avg Trading Volume0.02M

EPS Excl Extra (TTM)$-30.32

Revenue Growth (5Y)24.62%

EPS (Annual)$-45.26

ROI (Annual)-58.87%

Gross Margin (Annual)-4.12%

Net Profit Margin (5Y Avg)-14.81%

Cash / Share (Quarterly)$5.44

Revenue Growth QoQ (YoY)8.60%

ROA (Last FY)-22.53%

Revenue Growth TTM (YoY)2.81%

EBITD / Share (TTM)$-14.07

ROE (5Y Avg)-1098.22%

Operating Margin (TTM)-9.89%

Cash Flow / Share (Annual)$-27.77

P/B Ratio0.42x

P/B Ratio (Quarterly)1.08x

Net Income / Employee (Annual)$-462,300

EV / Revenue (TTM)0.09x

Net Interest Coverage (TTM)-4.83x

ROA (TTM)-14.75%

EPS Incl Extra (Annual)$-45.26

Current Ratio (Annual)0.24x

Quick Ratio (Quarterly)0.43x

3-Month Avg Trading Volume0.03M

52-Week Price Return-53.06%

Revenue / Employee (TTM)$4,696,400

Tangible BV / Share (Quarterly)$-4.38

P/S Ratio (Annual)0.02x

Asset Turnover (Annual)2.22x

52-Week High$16.89

Operating Margin (5Y Avg)-46.27%

EPS Excl Extra (Annual)$-45.26

26-Week Price Return71.78%

Quick Ratio (Annual)0.22x

13-Week Price Return-61.74%

Total Debt / Equity (Annual)2.04x

Current Ratio (Quarterly)0.46x

Enterprise Value$129.06M

Revenue / Share Growth (5Y)107.26%

Asset Turnover (TTM)2.25x

Revenue / Employee (Annual)$4,559,600

Pretax Margin (Annual)-22.00%

Cash / Share (Annual)$7.61

3-Month Return Std Dev69.34%

Gross Margin (5Y Avg)-1.95%

Net Income / Employee (TTM)$-307,600

ROE (Last FY)-178.90%

Net Interest Coverage (Annual)-2.74x

EPS Basic Excl Extra (Annual)$-45.26

Receivables Turnover (TTM)13.14x

Total Debt / Equity (Quarterly)1.67x

EPS Incl Extra (TTM)$-30.32

Receivables Turnover (Annual)13.65x

ROI (TTM)3.87%

P/S Ratio (TTM)0.02x

Pretax Margin (5Y Avg)-47.51%

Revenue / Share (Annual)$446.34

Tangible BV / Share (Annual)$-17.92

Price vs S&P 500 (52W)-68.59%

Year-to-Date Return18.62%

5-Day Price Return-6.76%

EPS Normalized (Annual)$-45.26

ROA (5Y Avg)-16.80%

Net Profit Margin (Annual)-10.14%

Month-to-Date Return-38.80%

Cash Flow / Share (TTM)$-7.38

EBITD / Share (Annual)$-56.94

Operating Margin (Annual)-18.53%

LT Debt / Equity (Annual)1.18x

ROI (5Y Avg)-110.68%

LT Debt / Equity (Quarterly)1.36x

EPS Basic Excl Extra (TTM)$-30.32

P/B Ratio (Annual)1.06x

Pretax Margin (TTM)-15.12%

Book Value / Share (Annual)$23.31

Price vs S&P 500 (13W)-64.42%

Beta1.86x

Revenue / Share (TTM)$447.01

ROE (TTM)10.31%

52-Week Low$1.52

vGradeA

gGradeC

mGradeD

vgmGradeC

PIII Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 10, 2026	-$1.90	-$0.63	+66.75%(+$1.27)
Q1 2026	May 14, 2026	-$3.50	$0.32	+109.13%(+$3.82)
Q4 2025	Mar 26, 2026	-$9.46	-$23.02	-143.21%(-$13.56)
Q3 2025	Nov 13, 2025	-$6.04	-$9.67	-60.19%(-$3.63)
Q2 2025	Aug 14, 2025	-$4.30	-$6.23	-44.88%(-$1.93)

PIII Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.00

Industry Peers — Health Services(21)

Symbol	Value Score	Growth Score	Momentum Score	P/E Ratio (Annual)	Revenue Growth TTM (YoY)	Operating Margin (TTM)	ROE (TTM)	Price
PIIIP3 Health Partners Inc. Common Stock	A	C	D	—	2.8%	-9.9%	10.3%	$4.14
LFSTLifeStance Health Group, Inc. Common Stock	D	A	B	464.3x	61.1%	4.9%	3.4%	$11.74
PRVAPrivia Health Group, Inc. Common Stock	C	B	C	125.5x	24.1%	1.9%	3.8%	$22.52
WGSGeneDx Holdings Corp. Class A Common Stock	F	B	D	—	25.4%	-21.8%	-38.7%	$63.61
PNTGThe Pennant Group, Inc. Common Stock	D	B	B	49.4x	37.9%	5.7%	9.5%	$41.87
USPHUS Physical Therapy Inc	C	D	C	32.3x	11.3%	9.4%	6.8%	$85.71
INNVInnovAge Holding Corp. Common Stock	D	C	C	—	15.9%	0.3%	-1.1%	$8.85
OMDAOmada Health, Inc. Common Stock	D	B	D	—	8.3%	-0.8%	1.8%	$17.63
SRTAStrata Critical Medical, Inc. Class A Common Stock	B	B	C	9.7x	18.8%	-8.0%	14.3%	$4.54
ALPSALPS Group Inc Ordinary Share	—	—	D	—	—	—	—	$0.34
EUDAEUDA Health Holdings Limited Ordinary Shares	C	B	C	—	66.9%	-36.5%	-1.8%	$15.40
DCGODocGo Inc. Common Stock	A	D	F	3.3x	-32.4%	-62.3%	-115.6%	$0.27
ATPCAgape ATP Corporation Common Stock	B	F	F	—	-26.9%	-295.9%	-5.1%	$1.57
VSEEVSee Health, Inc. Common Stock	A	D	F	—	—	-77.4%	-177.5%	$2.10
EUDAWEUDA Health Holdings Limited Warrant	—	—	C	—	—	—	—	$0.03
EVSDEaton Vance Short Duration Income ETF	—	—	C	—	—	—	—	$50.04
PIIIWP3 Health Partners Inc. Warrant	—	—	D	—	—	—	—	$0.01
SRTAWStrata Critical Medical, Inc. Warrants	—	—	F	—	—	—	—	$0.00
TALKTalkspace, Inc. Common Stock	F	B	B	111.7x	22.6%	-1.2%	1.0%	$0.00
TALKWTalkspace, Inc. Warrant	—	—	F	—	—	—	—	$0.00
VSEEWVSee Health, Inc. Warrant	—	—	D	—	—	—	—	$0.02
WGSWWGeneDx Holdings Corp. Warrant	—	—	F	—	—	—	—	$0.00

About P3 Health Partners Inc. Common Stock

P3 Health Partners is a population health management company that coordinates care delivery across networks of community-based healthcare providers. The company aggregates existing healthcare resources to facilitate integrated, coordinated care aimed at improving patient outcomes and reducing costs. Its physician-led model aligns providers around shared quality and cost metrics.